Provided by Tiger Trade Technology Pte. Ltd.

Forte BioSciences Inc

21.59
-0.4100-1.86%
Post-market: 21.590.00000.00%16:10 EDT
Volume:123.97K
Turnover:2.70M
Market Cap:442.14M
PE:-5.09
High:22.35
Open:21.79
Low:20.69
Close:22.00
52wk High:35.80
52wk Low:7.78
Shares:20.48M
Float Shares:17.40M
Volume Ratio:0.51
T/O Rate:0.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.2454
EPS(LYR):-12.1671
ROE:-188.40%
ROA:-83.90%
PB:10.50
PE(LYR):-1.77

Loading ...

Forte Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

Forte Biosciences Inc expected to post a loss of $1.08 a share - Earnings Preview

Reuters
·
May 12

Forte Biosciences grants new hire options, RSUs covering 100,000 shares

Reuters
·
May 12

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

THOMSON REUTERS
·
May 12

Forte Biosciences Q1 EPS $(1.24) Misses $(1.19) Estimate

Benzinga
·
May 11

Forte Biosciences Q1 FY26 net loss widens to $22.14 million

Reuters
·
May 11

Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update

THOMSON REUTERS
·
May 11

Forte Biosciences Q1 Income From Operations USD -22.439 Million

THOMSON REUTERS
·
May 11

Top Midday Gainers

MT Newswires Live
·
Apr 10

BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman

Reuters
·
Apr 10

Forte Biosciences Up Nearly 33%, on Pace for Largest Percent Increase Since May 2025 -- Data Talk

Dow Jones
·
Apr 09

BRIEF-Forte Biosciences Announces Pricing Of $150 Million Public Offering

Reuters
·
Apr 09

Forte Biosciences Inc - Announces Pricing of 5,709,936 Share Public Offering at $26.27 per Share

THOMSON REUTERS
·
Apr 09

BUZZ-Forte Biosciences falls after launching stock offering

Reuters
·
Apr 09

Forte Biosciences launches underwritten public offering of common stock

Reuters
·
Apr 09

Forte Biosciences Announces Proposed Public Offering

THOMSON REUTERS
·
Apr 09

Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and Forte Biosciences (FBRX)

TIPRANKS
·
Apr 01

Forte Biosciences Q4 EPS $(1.45) Misses $(1.06) Estimate

Benzinga
·
Apr 01

Forte Biosciences FY25 net loss climbs to $69M; R&D expenses jump to $58M

Reuters
·
Apr 01

Forte Biosciences FY Net Income USD -69.375 Million

THOMSON REUTERS
·
Apr 01